Keith T. Flaherty, Director at Loxo Oncology, Inc. (LOXO), sold 15,000 shares at $26.00 ($390K) on 2016-08-11, disclosed to the SEC on 2016-08-12.
Open-market sale of $390k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LOXO | SELL | 2017-08-23 | $775K | — | Filing → |
| LOXO | SELL | 2017-05-24 | $649K | — | Filing → |
| LOXO | SELL | 2017-02-23 | $601K | — | Filing → |